Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 16:00:29 2024-05-09 EDT 5-day change 1st Jan Change
28.18 USD +1.18% Intraday chart for Pfizer, Inc. +1.73% -2.12%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 60.29B 82.52B Sales 2025 * 62.64B 85.73B Capitalization 160B 219B
Net income 2024 * 7.18B 9.83B Net income 2025 * 11.14B 15.25B EV / Sales 2024 * 3.62 x
Net Debt 2024 * 58.11B 79.54B Net Debt 2025 * 49.97B 68.39B EV / Sales 2025 * 3.35 x
P/E ratio 2024 *
20.2 x
P/E ratio 2025 *
13.9 x
Employees 88,000
Yield 2024 *
5.89%
Yield 2025 *
5.99%
Free-Float 59.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.12%
1 week+1.73%
Current month+9.99%
1 month+5.23%
3 months+2.25%
6 months-5.05%
Current year-2.12%
More quotes
1 week
27.32
Extreme 27.32
28.49
1 month
25.20
Extreme 25.2
28.49
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-09 28.18 -0.32% 46,614,152
24-05-08 28.27 +1.80% 39,087,790
24-05-07 27.77 -1.38% 65,606,379
24-05-06 28.16 +1.26% 59,899,707
24-05-03 27.81 +0.40% 60,568,852

Delayed Quote Nyse, May 09, 2024 at 04:00 pm

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.18 USD
Average target price
31.94 USD
Spread / Average Target
+13.34%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW